KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Liabilities and Shareholders Equity (2016 - 2026)

Biogen has reported Liabilities and Shareholders Equity over the past 18 years, most recently at $29.5 billion for Q1 2026.

  • For Q1 2026, Liabilities and Shareholders Equity rose 5.17% year-over-year to $29.5 billion; the TTM value through Mar 2026 reached $116.5 billion, up 4.73%, while the annual FY2025 figure was $29.4 billion, 4.96% up from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 was $29.5 billion at Biogen, roughly flat from $29.4 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $29.5 billion in Q1 2026 and troughed at $23.6 billion in Q1 2022.
  • A 5-year average of $26.9 billion and a median of $26.8 billion in 2023 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: dropped 1.01% in 2022 and later increased 13.43% in 2023.
  • Year by year, Liabilities and Shareholders Equity stood at $24.6 billion in 2022, then increased by 9.33% to $26.8 billion in 2023, then increased by 4.49% to $28.0 billion in 2024, then increased by 4.96% to $29.4 billion in 2025, then rose by 0.15% to $29.5 billion in 2026.
  • Business Quant data shows Liabilities and Shareholders Equity for BIIB at $29.5 billion in Q1 2026, $29.4 billion in Q4 2025, and $29.2 billion in Q3 2025.